Study | Reason for exclusion |
---|---|
Abuzzahab 1977 | Allocation: not clear. Participants: chronic schizophrenia. Interventions: trifluoperazine versus penfluridol versus placebo. Outcomes: no usable data (literature review). |
Barron 1961 | Allocation: random. Participants: 'chronically mentally ill'. Interventions: trifluoperazine versus chlorprothixene versus placebo. Outcomes: no usable data (cross‐over study ‐ no results available pre‐cross‐over). |
Cahan 1960 | Allocation: not randomised. |
Coons 1962 | Allocation: randomised. Participants: mixed diagnoses. |
Hamilton 1963 | Allocation: randomised. Participants: chronic schizophrenia. Interventions: trifluoperazine versus prochlorperazine versus placebo. Outcomes: no usable data. |
Holden 1971 | Allocation: not clear. Participants: schizophrenia. Interventions: trifluoperazine versus thiothixene. |
Hunt 1967 | Allocation: random. Participants: schizophrenia. Interventions: trifluoperazine versus oxypertine. |
Leff 1971 | Allocation: not randomised. |
Leff 1973 | Allocation: randomised. Participants: schizophrenia. Interventions: pooled data from two RCTs ‐ fluphenazine decanoate versus placebo and trifluoperazine versus placebo. |
Madgwick 1958 | Allocation: not stated. Participants: chronic schizophrenia. Interventions: trifluoperazine ‐ once stabilised, half continued trifluoperazine, half withdrawn using placebo. Outcomes: no usable data (withdrawal study). |
Morton 1968 | Allocation: not randomised. |
Stanley 1961 | Allocation: not randomised. |
Weckowicz 1960 | Allocation: not randomised |
Weston 1961 | Allocation: not randomised. |
RCT ‐ randomised controlled trial